EMA Guidance on Trial Mgmt during COVID-19

European Medicines Agency Health Care, Pharma Industry, Strategic Planning

The impact of COVID-19 on ongoing trials, on opening a new trial site in an existing trial, ongoing recruitment and continued involvement of participants in the trial, or on starting of new trials needs to be considered. Read this EMA Guidance to learn more about managing your clinical trials during this pandemic.

Read the Guidance now